Since founding The Singularity Group in 2017, Pflugi has transitioned from her background in engineering and biotechnology to managing collective assets under a new FINMA license. She describes her current focus as scaling the firm’s equity investment strategy, a goal she balances with a candid view of her profession. While many outsiders imagine high-stakes analysis, Pflugi notes that the day-to-day reality involves a significant volume of administrative work, which she argues is necessary to support the research she finds deeply compelling.
Her approach to career and life remains rooted in a desire to understand systemic functions, whether in biotechnology or financial markets. She views mental flexibility as a rare and cultivated skill, admitting that even she finds it challenging to maintain an open mind when faced with deeply held convictions. For the future, she harbors an ambitious goal: to see her firm’s strategies adopted by major institutions like the Swiss National Bank, potentially providing investors with higher returns and reduced risk to support broader human endeavors, from healthcare to space exploration.





Comments (0)
No comments yet. Be the first!